Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
International Journal of Cancer|February 10, 2007
MAGE-A9 mRNA and protein expression in bladder cancerValérie Picard, Alain Bergeron, Hélène Larue, et al.
Nature Reviews. Urology|August 28, 2013
Toll-like receptors in urothelial cells--targets for cancer immunotherapyHélène LaRue, Cherifa Ayari, Alain Bergeron, et al.
The Journal of Urology|March 23, 2011
Toll-like receptors in normal and malignant human bladdersCherifa Ayari, Alain Bergeron, Hélène LaRue, et al.
Trends in Molecular Medicine|May 15, 2025
New insights into gut microbiota-prostate cancer crosstalkJalal Laaraj, Gabriel Lachance, Alain Bergeron, et al.
Urology Annals|November 6, 2014
Cystatin C for early detection of acute kidney injury after laparoscopic partial nephrectomyAnwar Alesawi, Geneviève Nadeau, Alain Bergeron, et al.
Cancer Immunology, Immunotherapy : CII|January 14, 2016
Poly(I:C) potentiates Bacillus Calmette-Guérin immunotherapy for bladder cancerCherifa Ayari, Marjorie Besançon, Alain Bergeron, et al.
International Journal of Cancer|June 18, 2009
High frequency of MAGE-A4 and MAGE-A9 expression in high-risk bladder cancerAlain Bergeron, Valérie Picard, Hélène LaRue, et al.
World Journal of Urology|July 18, 2020
Androgen receptor and immune cell PD-L1 expression in bladder tumors predicts disease recurrence and survivalPaul Toren, Hervé Brisson, David Simonyan, et al.
European Urology Open Science|October 17, 2022
Combining Antiandrogens with Immunotherapy for Bladder Cancer TreatmentMarjorie Besançon, Typhaine Gris, France-Hélène Joncas, et al.
Human Pathology|April 12, 2013
High level of mature tumor-infiltrating dendritic cells predicts progression to muscle invasion in bladder cancerCherifa Ayari, Hélène LaRue, Hélène Hovington, et al.
Pageof 6